期刊文献+

心脏磁共振评估肥厚型心肌病微循环障碍的研究进展 被引量:8

Research Progress of Cardiac Magnetic Resonance in Evaluating Microvascular Dysfunction of Hypertrophic Cardiomyopathy
下载PDF
导出
摘要 冠状动脉微血管功能障碍(CMD)是肥厚型心肌病患者心肌缺血的主要原因。CMD是发生左心室不良重构、收缩功能障碍和恶性心律失常的预测因子,因此准确评估CMD对肥厚型心肌病的危险分层、治疗决策制订及预后评估具有重要意义。心脏磁共振在CMD诊断中具有重要作用。本文拟对心脏磁共振评估肥厚型心肌病微循环障碍的研究进展进行综述。 Coronary microvascular dysfunction(CMD)is the main cause of myocardial ischemia in patients with hypertrophic cardiomyopathy.CMD is a predictor of left ventricular remodeling,systolic dysfunction and malignant arrhythmia.Therefore,accurate assessment of CMD is of great significance for risk stratification,therapeutic decision-making and prognosis assessment of hypertrophic cardiomyopathy.Cardiac magnetic resonance plays an important role in the diagnosis of CMD.This paper reviews the progress of cardiac magnetic resonance in the evaluation of CMD in hypertrophic cardiomyopathy.
作者 陈梓娴 张莉 南江 庄辛 郭顺林 雷军强 CHEN Zixian;ZHANG Li;NAN Jiang;ZHUANG Xin;GUO Shunlin;LEI Junqiang(Department of Radiology,the First Hospital of Lanzhou University,Gansu Intelligent Imaging Medical Engineering Research Center,Precision Image Collaborative Innovation Gansu International Science and Technology Cooperation Base,Gansu Radiology Clinical Medicine Research Center,Lanzhou 730000,China;不详)
出处 《中国医学影像学杂志》 CSCD 北大核心 2023年第2期180-184,共5页 Chinese Journal of Medical Imaging
基金 兰州市科技计划项目(2020-2D-80) 兰州大学第一医院院内基金(ldyyyn2019-78,ldyyyn2015-06)。
关键词 肥厚型心肌病 冠状动脉微血管功能障碍 磁共振成像 综述 Hypertrophic cardiomyopathy Coronary microvascular dysfunction Magnetic resonance imaging Review
  • 相关文献

参考文献8

二级参考文献40

  • 1向定成,龚志华,建新,洪长江,邱建,马骏.Dose protocols of acetylcholine test in Chinese[J].Chinese Medical Journal,2004(10):1564-1566. 被引量:3
  • 2赵世华,闫朝武,杨敏福,陆敏杰,蒋世良,李世国,张岩,刘琼,刘玉清,何作祥.磁共振心肌灌注延迟增强与核素心肌灌注/代谢显像识别存活心肌对比研究[J].中华心血管病杂志,2006,34(12):1072-1076. 被引量:26
  • 3FU Xiang-hua FAN Wei-ze GU Xin-shun WEI Yong-yun JIANG Yun-fa WU Wei-li LI Shi-qiang HAO Guo-zhen WEI Qing-min XUE Ling.Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction[J].Chinese Medical Journal,2007(14):1226-1231. 被引量:38
  • 4Petersen SE, Jerosch-Herold M, Hudsmith LE, et aL Evidence for microvascular dysfunction in hypertrophic eardiomyopathy: New insights from multiparametri magnetic resonance imaging. Circulation, 2007,115(18) : 2418-2425.
  • 5To AC, Dhilion A, Desai MY. Cardiac magnetic resonance in hy- pertrophic cardiomyopathy. JACC Cardiovasc Imaging, 2011, 4 (10) : 1123-1137.
  • 6Knaapen P, Germans T, Camici PG, et al. Determinants of coro- nary microvascular dysfunction in symptomatic hypertrophic car- diomyopathy. Am J Physiol Heart Cite Physiol, 2008, 294 (2): H986-H993.
  • 7Cecchi F, Sgalambro A, Baldi M, et al. Microvascular dysfunc- tion, myocardial ischemia, and progression to heart failure in pa- tients with hypertrophic cardiomyopathy. J Cardiovasc Transl Res, 2009,2(4) :452-461.
  • 8Maron BJ. Contemporary insights and strategies for risk stratifi- cation and prevention of sudden death in hypertrophic cardiomyop- athy. Circulation, 2010,121(3) :445-456.
  • 9O'hanlon R, Grasso A, Roughton M, et al. Prognostic signifi- cance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coil Cardiol, 2010,56(11) :867-874.
  • 10Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dys- function and prognosis in hypertrophic cardiomyopathy. N Engl J Med, 2003,349(11) :1027-1035.

共引文献510

同被引文献108

引证文献8

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部